Third-line enfortumab vedotin improved outcomes in metastatic urothelial carcinoma, per real-world data from the EV-301 trial ...
A WOMAN from Northwich has become the first skin cancer patient to benefit from a new high-tech machine at The Christie ...
TuHURA Biosciences, a biotech firm, is advancing DNA-based immunotherapy for cancer. Read what warrants a Hold rating for ...
A WOMAN from Northwich has become the first skin cancer patient to benefit from a new high-tech machine at The Christie hospital. Muriel Large from Davenham, has completed a course of treatment on the ...
Dr. Daniel Olson is hoping it's the first step in a whole new way of treating cancers like the one that was threatening Alla ...
Melanoma is one of the most aggressive skin cancers, with more than 300,000 new cases reported worldwide each year. In Europe ...
New research published in Nature Communications reveals how cancer cells are altered by their surroundings, enabling them to ...
Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results